Exelon is a cholinesterase inhibitor, a type of medicine prescribed for people in the early or middle stages of Alzheimer's disease. Though not a cure, Exelon has been shown to be an effective medicine for treating the symptoms of mild to moderate Alzheimer's disease. It can slow the progression of symptoms and help people with mild to moderate Alzheimer's disease stay connected longer to the relationships and activities they value and enjoy.
Product developed by:
Prof. Marta Weinstock-Rosin, Department of Pharmacology, Hebrew University